ATEC vs. LMNX, GNMK, LMAT, MDXG, KIDS, ITGR, IART, ATRC, SRDX, and OFIX
Should you be buying Alphatec stock or one of its competitors? The main competitors of Alphatec include Luminex (LMNX), GenMark Diagnostics (GNMK), LeMaitre Vascular (LMAT), MiMedx Group (MDXG), OrthoPediatrics (KIDS), Integer (ITGR), Integra LifeSciences (IART), AtriCure (ATRC), Surmodics (SRDX), and Orthofix Medical (OFIX). These companies are all part of the "medical" sector.
Alphatec (NASDAQ:ATEC) and Luminex (NASDAQ:LMNX) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, valuation, profitability, media sentiment, institutional ownership, analyst recommendations, community ranking, dividends and risk.
Alphatec received 55 more outperform votes than Luminex when rated by MarketBeat users. Likewise, 56.68% of users gave Alphatec an outperform vote while only 45.84% of users gave Luminex an outperform vote.
In the previous week, Alphatec had 5 more articles in the media than Luminex. MarketBeat recorded 6 mentions for Alphatec and 1 mentions for Luminex. Alphatec's average media sentiment score of 1.19 beat Luminex's score of 0.50 indicating that Alphatec is being referred to more favorably in the media.
Alphatec has a beta of 1.48, meaning that its share price is 48% more volatile than the S&P 500. Comparatively, Luminex has a beta of 0.56, meaning that its share price is 44% less volatile than the S&P 500.
66.4% of Alphatec shares are owned by institutional investors. Comparatively, 87.8% of Luminex shares are owned by institutional investors. 22.8% of Alphatec shares are owned by company insiders. Comparatively, 6.6% of Luminex shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.
Alphatec currently has a consensus price target of $22.89, suggesting a potential upside of 135.72%. Given Alphatec's higher probable upside, analysts clearly believe Alphatec is more favorable than Luminex.
Luminex has a net margin of 5.39% compared to Alphatec's net margin of -37.45%. Luminex's return on equity of 4.66% beat Alphatec's return on equity.
Luminex has lower revenue, but higher earnings than Alphatec. Alphatec is trading at a lower price-to-earnings ratio than Luminex, indicating that it is currently the more affordable of the two stocks.
Summary
Alphatec beats Luminex on 9 of the 17 factors compared between the two stocks.
Get Alphatec News Delivered to You Automatically
Sign up to receive the latest news and ratings for ATEC and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding ATEC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Alphatec Competitors List
Related Companies and Tools
